🔎 Trials Near Me

Home › Bone Cancer › NCT06409013

Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma

RecruitingObservational study

Sarcoma Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Patients with biopsy-proven bone or soft tissue sarcoma undergoing resection

Exclusion Criteria:

* Chronic kidney disease
* Anaphylaxis to dyes

About the study

This study evaluates the effectiveness of intraoperative indocyanine green dye and fluoroscopic technology in confirming negative margins after tumor removal.

What is being tested

Sponsor: Mayo Clinic · Participants: 75 · Started: Mar 14, 2024

Contact the study team

Official record on ClinicalTrials.gov — NCT06409013

Locations in the U.S.

MinnesotaMayo Clinic in Rochester, Rochester

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.